Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-26

Clinical Trial Update: Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating capecitabine, oxaliplatin, selenomethionine, and radiation therapy in patients undergoing surgery for newly diagnosed stage II/III re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)
  • Radiation therapy
  • Selenomethionine (selenomethionine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-26